|
| Thursday, February 8, 2024 |
|
|
NEC Face Recognition Technology Ranks First in NIST Accuracy Testing |
| NEC Corporation today announced that its face recognition technology has been ranked the world's most accurate in a benchmark test conducted by the globally recognized U.S. National Institute of Standards and Technology (NIST). more info >> |
|
| Wednesday, February 7, 2024 |
|
|
NEC Strengthens Supply Chain Security with Technology to Detect Software Vulnerabilities through Static Analysis of Executable Files |
| NEC Corporation has developed a technology that strengthens the security of supply chains by detecting vulnerabilities in software from the binary code(1) of executable files, without the need for source code. more info >> |
|
| Tuesday, February 6, 2024 |
|
|
NEC named to the CDP "A List" for advanced Climate Change and Water Security initiatives five years in a row |
| NEC Corporation (NEC; TSE: 6701) has been recognized for leadership in corporate sustainability by global environmental non-profit CDP, securing a place on its prestigious "A List" five years in a row for tackling climate change, as well as acting to protect water security. more info >> |
|
| Thursday, February 1, 2024 |
|
|
NEC joins Columbia University-led National Science Foundation Engineering Research Center for Smart Streetscapes (CS3) |
| NEC Corporation has concluded a membership agreement with the U.S.-based National Science Foundation Engineering Research Center for Smart Streetscapes (CS3), a Columbia University-led initiative supporting the development of a rich ecosystem of streetscape applications. more info >> |
|
| Friday, January 26, 2024 |
|
|
NEC Showcases AI Technologies and Networking Strengths at MWC Barcelona 2024 |
| NEC Corporation (NEC; TSE: 6701) announced today that it will showcase its latest digital transformation capabilities, including a wide range of AI and global network technologies, at MWC Barcelona 2024 from February 26 - 29 at Hall 2, Stand 2H40. more info >> |
|
| Thursday, January 25, 2024 |
|
|
NEC receives order for KIOSK enabling one-stop immigration and customs declaration procedures at Haneda Airport Terminal 2 |
| NEC Corporation today announced that it has received an order from the Immigration Services Agency and Japan Customs for the installation of Immigration & Customs Declaration KIOSKs that will be jointly used for immigration and customs inspections to facilitate seamless immigration and customs procedures at Haneda Airport Terminal 2, as well as the design of related systems. more info >> |
|
| Wednesday, January 17, 2024 |
|
|
NEC, Kimuraya and ABEMA use AI to develop bread with a "taste of love" |
| NEC Corporation, together with Kimuraya Sohonten Co., a long-established bread maker, and Abema TV, a video streaming service, have teamed up to produce bread with flavors inspired by the romantic Japanese television program, "I Fell in Love with you Today." more info >> |
|
| Friday, January 12, 2024 |
|
|
NEC Wins Telecom Review Excellence Award for Most Innovative Product/Service Globally for Telco B2B Leadership |
| NEC Corporation (TSE: 6701), a leading global IT and network transformation services provider, today announced that the company has been named winner of the Most Innovative Product/Service (Vendor) - Global award at the Telecom Review Leaders' Summit 2023. more info >> |
|
|
NEC Completes Submarine Cable System for India's BSNL Connecting Kochi and the Lakshadweep Islands |
| NEC Corporation India (NEC India) together with NEC Corporation today announced the successful completion of a flagship optical submarine cable system in Southern India connecting Kochi and the Lakshadweep Islands. more info >> |
|
| Tuesday, January 9, 2024 |
|
|
Transgene and NEC Extend their Collaboration to Continue Joint Clinical Development of Neoantigen Cancer Vaccine TG4050 |
| Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation, a leader in IT, network and AI technologies, have announced the signing of a further development collaboration agreement to continue the clinical evaluation of the individualized neoantigen cancer vaccine TG4050. more info >> |
|
|
|
